RecruitingNot applicableNCT05521776

Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Catherine DENEUX, MD, PhD
Institut National de la Santé Et de la Recherche Médicale, France
Intervention
First-trimester preeclampsia screening (FMF triple test)(procedure)
Enrollment
14500 target
Eligibility
18 years · FEMALE
Timeline
20232027

Study locations (22)

Collaborators

INSERM, Epopé team · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05521776 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials